Skip to main content
Top
Published in: European Journal of Epidemiology 11/2008

01-11-2008 | CANCER

Lifetime total physical activity and prostate cancer risk: a population-based case–control study in Sweden

Authors: Fredrik Wiklund, Ylva Trolle Lageros, Ellen Chang, Katarina Bälter, Jan-Erik Johansson, Hans-Olov Adami, Henrik Grönberg

Published in: European Journal of Epidemiology | Issue 11/2008

Login to get access

Abstract

The etiologic role of physical activity in prostate cancer development is unclear. We assessed the association between lifetime total physical activity and prostate cancer risk in a Swedish population-based case–control study comprising 1,449 incident prostate cancer cases and 1,118 unaffected population controls. Information regarding physical activity was obtained via a self-administered questionnaire assessing occupational, household, and recreational activity separately at various ages throughout an individual’s lifetime. Clinical data (TNM-classification, Gleason sum and PSA) was obtained from linkage to the National Prostate Cancer Registry. Overall, we observed no association between lifetime total physical activity and prostate cancer risk (odds ratio [OR] = 1.04, 95% confidence interval [CI] = 0.77–1.41 for ≥49.7 vs. <41.9 metabolic equivalent-hours per day). There was a significantly increased risk of prostate cancer in the most active men compared with the least active men in household (OR = 1.44, 95% CI = 1.08–1.92) and recreational physical activity (OR = 1.56, 95% CI = 1.16–2.10). Comparing the most active with the least active men, total physical activity was not associated with either localized disease (OR = 0.95, 95% CI = 0.67–1.34) or advanced disease (OR = 1.19, 95% CI = 0.83–1.71). These findings do not support the hypothesis that physical activity uniformly protects against prostate cancer development.
Literature
7.
go back to reference Krishnadasan A, Kennedy N, Zhao Y, Morgenstern H, Ritz B. Nested case–control study of occupational physical activity and prostate cancer among workers using a job exposure matrix. Cancer Causes Control. 2008;19:107–14. doi:10.1007/s10552-007-9076-7.PubMedCrossRef Krishnadasan A, Kennedy N, Zhao Y, Morgenstern H, Ritz B. Nested case–control study of occupational physical activity and prostate cancer among workers using a job exposure matrix. Cancer Causes Control. 2008;19:107–14. doi:10.​1007/​s10552-007-9076-7.PubMedCrossRef
10.
14.
go back to reference Nilsen TI, Romundstad PR, Vatten LJ. Recreational physical activity and risk of prostate cancer: a prospective population-based study in Norway (the HUNT study). Int J Cancer. 2006;119:2943–7. doi:10.1002/ijc.22184.PubMedCrossRef Nilsen TI, Romundstad PR, Vatten LJ. Recreational physical activity and risk of prostate cancer: a prospective population-based study in Norway (the HUNT study). Int J Cancer. 2006;119:2943–7. doi:10.​1002/​ijc.​22184.PubMedCrossRef
15.
go back to reference Friedenreich CM, McGregor SE, Courneya KS, Angyalfi SJ, Elliott FG. Case–control study of lifetime total physical activity and prostate cancer risk. Am J Epidemiol. 2004;159:740–9. doi:10.1093/aje/kwh106.PubMedCrossRef Friedenreich CM, McGregor SE, Courneya KS, Angyalfi SJ, Elliott FG. Case–control study of lifetime total physical activity and prostate cancer risk. Am J Epidemiol. 2004;159:740–9. doi:10.​1093/​aje/​kwh106.PubMedCrossRef
16.
go back to reference Lindmark F, Zheng SL, Wiklund F, Bensen J, Balter KA, Chang B, et al. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst. 2004;96:1248–54.PubMedCrossRef Lindmark F, Zheng SL, Wiklund F, Bensen J, Balter KA, Chang B, et al. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst. 2004;96:1248–54.PubMedCrossRef
17.
go back to reference Varenhorst E, Garmo H, Holmberg L, Adolfsson J, Damber JE, Hellstrom M, et al. The National Prostate Cancer Register in Sweden 1998–2002: trends in incidence, treatment and survival. Scand J Urol Nephrol. 2005;39:117–23. doi:10.1080/00365590510007793.PubMedCrossRef Varenhorst E, Garmo H, Holmberg L, Adolfsson J, Damber JE, Hellstrom M, et al. The National Prostate Cancer Register in Sweden 1998–2002: trends in incidence, treatment and survival. Scand J Urol Nephrol. 2005;39:117–23. doi:10.​1080/​0036559051000779​3.PubMedCrossRef
19.
24.
go back to reference Platz EA, Leitzmann MF, Michaud DS, Willett WC, Giovannucci E. Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study. Cancer Res. 2003;63:8542–8.PubMed Platz EA, Leitzmann MF, Michaud DS, Willett WC, Giovannucci E. Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study. Cancer Res. 2003;63:8542–8.PubMed
25.
go back to reference Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr. 2002;132:3456S–64S.PubMed Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr. 2002;132:3456S–64S.PubMed
27.
go back to reference Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control. 2002;13:929–35. doi:10.1023/A:1021911517010.PubMedCrossRef Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control. 2002;13:929–35. doi:10.​1023/​A:​1021911517010.PubMedCrossRef
28.
go back to reference Hellenius ML, Brismar KE, Berglund BH, de Faire UH. Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med. 1995;238:121–30.PubMedCrossRef Hellenius ML, Brismar KE, Berglund BH, de Faire UH. Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med. 1995;238:121–30.PubMedCrossRef
29.
go back to reference Haffner SM. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord. 2000;24(Suppl 2):S56–8. doi:10.1038/sj/ijo/0801279.PubMed Haffner SM. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord. 2000;24(Suppl 2):S56–8. doi:10.​1038/​sj/​ijo/​0801279.PubMed
30.
go back to reference Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort. J Clin Oncol. 2004;22:3104–12. doi:10.1200/JCO.2004.10.105.PubMedCrossRef Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort. J Clin Oncol. 2004;22:3104–12. doi:10.​1200/​JCO.​2004.​10.​105.PubMedCrossRef
31.
go back to reference Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, et al. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case–control study. J Natl Cancer Inst. 1998;90:911–5. doi:10.1093/jnci/90.12.911.PubMedCrossRef Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, et al. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case–control study. J Natl Cancer Inst. 1998;90:911–5. doi:10.​1093/​jnci/​90.​12.​911.PubMedCrossRef
32.
go back to reference Heikkila R, Aho K, Heliovaara M, Hakama M, Marniemi J, Reunanen A, et al. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study. Cancer. 1999;86:312–5. doi:10.1002/(SICI)1097-0142(19990715)86:2<312::AID-CNCR15>3.0.CO;2-7.PubMedCrossRef Heikkila R, Aho K, Heliovaara M, Hakama M, Marniemi J, Reunanen A, et al. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study. Cancer. 1999;86:312–5. doi:10.1002/(SICI)1097-0142(19990715)86:2<312::AID-CNCR15>3.0.CO;2-7.PubMedCrossRef
33.
go back to reference Reilly M, Pepe M. The relationship between hot-deck multiple imputation and weighted likelihood. Stat Med. 1997;16:5–19. doi:10.1002/(SICI)1097-0258(19970115)16:1<5::AID-SIM469>3.0.CO;2-8.PubMedCrossRef Reilly M, Pepe M. The relationship between hot-deck multiple imputation and weighted likelihood. Stat Med. 1997;16:5–19. doi:10.1002/(SICI)1097-0258(19970115)16:1<5::AID-SIM469>3.0.CO;2-8.PubMedCrossRef
35.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMed Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMed
Metadata
Title
Lifetime total physical activity and prostate cancer risk: a population-based case–control study in Sweden
Authors
Fredrik Wiklund
Ylva Trolle Lageros
Ellen Chang
Katarina Bälter
Jan-Erik Johansson
Hans-Olov Adami
Henrik Grönberg
Publication date
01-11-2008
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 11/2008
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-008-9294-7

Other articles of this Issue 11/2008

European Journal of Epidemiology 11/2008 Go to the issue